Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis

European Journal of Neurology

Volumn 10, Issue 1, 2003, Pages 35-38

  Murata, K ^a   Sugie, K ^a   Takamure, M ^a   Fujimoto, T ^a   Ueno, S ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Eosinophilic major basic protein; Eosinophilic myositis; Interleukin 5

Indexed keywords

INTERLEUKIN 5; MAJOR BASIC PROTEIN; MESSENGER RNA; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ELECTROMYOGRAM; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; RIBONUCLEASES; RNA, MESSENGER;

EID: 0037240780     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00481.x     Document Type: Article

References (12)

1. Abu-Ghazaleh RI, Gleich GJ, Prendergast FG (1992). Interaction of eosinophilgranule major basic protein with synthetic lipid bilayers: A mechanism for toxicity. J Membr Biol 128:153-164.
2. Cai B, Spencer MJ, Nakamura G, Tseng-Ong L, Tidball JG (2000). Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol 156:1789-1796.
3. Hall FC, Krausz T, Walport MJ (1995). Idiopathic eosinophilic myositis. QJ Med, Oxford University 88:581-586.
4. Ho KK, Ho AS, Leung RC, Lai CK, Lai KN (1998). The interleukin-5 messenger RNA expression in a patient with idiopathic hypereosinophilic syndrome. Clin Exp Allergy 28:889-892.
5. Kaufman LD, Kephart GM, Seidman RJ et al. (1993). The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum 36:1014-1024.
6. Kroegel C, Costabel U, Matthys H (1987). Mechanism of membrane damage mediated by eosinophil major basic protein. Lancet 1:1380-1381.
7. Kumamoto T, Ueyama H, Fujimoto S, Nagao S, Tsuda T (1994). Clinicopathologic characteristics of polymyositis patients with numerous tissue eosinophils. Acta Neurol Scand 94:110-114.
8. Meng Q, Ying S, Corrigan CJ et al. (1997). Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy 52:1095-1101.
9. Pickering MC, Walport MJ (1998). Eosinophilic myopathic syndromes. Curr Opin Rheumatol 10:504-510.
10. Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ (1987). Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1:643-647.
11. Trüeb RM, Lübbe J, Torricelli R, Panizzon RG, Wüthrich B, Burg G (1997). Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5. Arch Dermatol 133:203-206.
12. Zimmermann N, Daugherty BL, Stark JM, Rothenberg ME (2000). Molecular analysis of CCR-3 events in eosinophilic cells. J Immunol 164:1055-1064.